The pharmaceutical industry is undergoing one of the most intense periods of transformation in its history. Advances in science, the acceleration of digital technologies, evolving regulatory expectations, and mounting sustainability pressures are reshaping how medicines are developed and manufactured. Against this backdrop, the

The life sciences and diagnostics industry are undergoing a transformative digital evolution. Laboratory systems, electronic lab notebooks (ELN), TrackWise Digital (TWD), and enterprise content management platforms like Livelink are increasingly integrated with clinical, quality, and operational workflows. These technologies improve efficiency, traceability, and operational scalability, but...

Some people contribute to an industry. Others help define it. Jack Lysfjord did the latter.

From 20–22 April 2026, the 2026 ISPE Europe Annual Conference will bring pharmaceutical and biopharmaceutical professionals to Copenhagen, Denmark, for three days of focused discussion on the challenges shaping the future of regulated manufacturing. As...

The GAMP^® South Asia Community of Practice (CoP) convened on 5 February 2026 to explore one of the most important topics facing the life sciences today: how to build and use trustworthy AI, kindly hosted by the ISPE Philippines Affiliate. This virtual event brought together professionals across the region—many already experimenting with AI, others just beginning their journey—for an...

If someone had shared five years ago that industry would still be debating AI governance frameworks inside validation steering committees, it would have seemed unlikely. At the time, many genuinely believed the maturation of digital validation, especially with the publication of the

As pharmaceutical manufacturers accelerate digital transformation, many organizations face a familiar challenge: how to adopt modern technologies without increasing compliance risk or operational friction. The 2026 ISPE Europe Annual Conference brings industry leaders together to address exactly this tension—bridging innovation, quality, and regulatory expectations with proven, real-world...

AI is no longer a distant or experimental concept within pharmaceutical and biotechnology organizations. Across laboratories, manufacturing operations, and quality systems, AI-enabled tools are increasingly being piloted to accelerate insights, strengthen decision-making, and improve operational efficiency. Yet despite growing enthusiasm, many organizations encounter a consistent and familiar...

This blog post produced by the ISPE D/A/CH CoP Aseptic Processing – Subgroup Appropriate Technologies, synthesizes regulatory drivers from EU/PIC/S GMP Annex 1 and provides guiding principles for installing sterile format parts into open isolators, presenting stepwise transfer and handling strategies to protect critical surfaces, first air and to ensure product sterility.

Career advancement in the life sciences sector is increasingly shaped by the ability to integrate technical excellence with regulatory rigor and cross functional collaboration. As therapies become more complex and regulatory expectations continue to evolve, professionals must understand how manufacturing decisions, quality systems, and digital infrastructures directly influence product...

Artificial intelligence is no longer a future concept for pharmaceutical development and manufacturing—it is an active, rapidly evolving capability with real implications for quality, safety, and regulatory expectations. The latest ISPE podcast episode examines AI at the intersection of regulatory guidance and pharmaceutical innovation, featuring insights from two seasoned leaders: David...

The 2026 ISPE Europe Annual Conference in Copenhagen, Denmark, is set to highlight some of the most recent Guidance Documents to be published by ISPE. This year’s ISPE Spotlight Sessions, held in the ISPE Publications Lounge within the exhibits area, will feature five focused presentations during lunch and networking breaks on Monday, 20 April; Tuesday, 21 April; and Wednesday, 22 April.

As one of ISPE Shanghai’s most significant annual gatherings, the 2026 ISPE China Annual Conference, held on 21–22 May 2026, in Shanghai, China, is designed to convene industry leaders, regulatory authorities, engineers, researchers, technology providers, and other key stakeholders from across the pharmaceutical sectors. The event will provide a comprehensive platform for dialogue,...

Good manufacturing practices (GMP form the foundation of pharmaceutical quality, safety, and regulatory compliance. Every person working in pharmaceutical development, manufacturing, packaging, engineering, quality control (QC), quality assurance (QA), and support functions plays a vital role in ensuring that every product released to patients is safe, pure, and effective.